MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

13 hedge funds and large institutions have $3.62M invested in Stealth BioTherapeutics Corp. ADS in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
6
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$1.38M +$492K +313,182 +55%
IC
2
Ikarian Capital
Texas
$1.24M +$1.18M +750,417 +1,996%
SM
3
Sabby Management
Florida
$473K +$473K +301,575 New
Citadel Advisors
4
Citadel Advisors
Florida
$177K +$124K +78,804 +234%
BFM
5
Boothbay Fund Management
New York
$147K +$147K +93,411 New
Squarepoint
6
Squarepoint
New York
$100K +$100K +63,729 New
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$40K +$40K +25,264 New
HF
8
HRT Financial
New York
$28K +$28K +17,967 New
Morgan Stanley
9
Morgan Stanley
New York
$21K +$11.8K +7,661 +128%
UBS Group
10
UBS Group
Switzerland
$8K +$6.85K +4,083 +594%
SFS
11
Sowell Financial Services
Arkansas
$5K
Osaic Holdings
12
Osaic Holdings
Arizona
$2K +$817 +576 +69%
BBHC
13
Brown Brothers Harriman & Co
New York
$275
Mercer Global Advisors
14
Mercer Global Advisors
Colorado
-$75K -50,000 Closed
VF
15
Virtu Financial
New York
-$67K -44,337 Closed
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
-$41K -27,282 Closed
Goldman Sachs
17
Goldman Sachs
New York
-$22K -14,989 Closed
TSS
18
Two Sigma Securities
New York
-$22K -14,851 Closed